Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.64
-0.01-0.22%
Last update: Oct 12, 5:26 PM
$4.67
0.020.43%
Opus Genetics Inc (IRD) Stock Price, Quote, News & History
IRDNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Opus Genetics (NASDAQ:IRD) through any online brokerage.
Other companies in Opus Genetics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Opus Genetics has a consensus price target of $11.56.
The stock price for Opus Genetics (NASDAQ: IRD) is $4.67 last updated October 12, 2026 at 5:26 PM EDT.
There are no upcoming dividends for Opus Genetics.
Opus Genetics does not have any upcoming earnings scheduled.
There is no upcoming split for Opus Genetics.
Opus Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
